Islet allotransplantation in type I diabetic patients: effects of islet cell number on clinical outcome.
Department of General Surgery, San Raffaele Scientific Institute, University of Milan, Italy.
A
A
Secchi
C
C
Socci
P
P
Maffi
L
L
Falqui
F
F
Bertuzzi
P
P
De Nittis
L
L
Piemonti
M V
MV
Taglietti
V
V
Di Carlo
G
G
Pozza
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000097:blood; D002469:Cell Separation / Q000379:methods; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D007515:Islets of Langerhans / Q000166:cytology*; D016381:Islets of Langerhans Transplantation / Q000473:pathology* / Q000502:physiology*; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation; D008297:Male; D011182:Postoperative Care; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D001786:Blood Glucose; D002096:C-Peptide; D006442:Glycated Hemoglobin; D007328:Insulin